Rayana AI
Account
DHR
HOLD / NEUTRALNeutral
Composite
54.60
Technical
65.30
Fundamental
47.50
Rank
Price
208.36
Hurst
0.50
As of
Sep 17, 2026
Daily
Danaher Corporation
HealthcareDiagnostics & Research

Danaher Corporation manufactures and supplies equipment, instruments, and consumables for biotechnology, life sciences, and diagnostics applications across medical, research, and industrial sectors globally. The company's Biotechnology segment provides manufacturing technologies and services for drug development and production, including filtration and purification systems. Its Life Sciences segment offers analytical instruments such as mass spectrometers and flow cytometers, along with reagents and sample preparation products, while the Diagnostics segment supplies clinical diagnostic instruments and software used by hospitals and laboratories.

Market cap
$149.4B
P/E (trailing)
37.15
P/E (forward)
22.85
PEG ratio
1.25
Dividend yield
77.00%
Beta
0.81
52w range
160.93 – 242.80
Return on equity
+7.61%
Profit margin
+15.95%
Revenue growth
+5.50%
Earnings growth
+59.70%
Price history

1Y: 212.50 (+9.6%) · range 161.57–241.04

Cycle position
40/ 100 cycle scoreAPPROACHING ENTRY
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 22 · NOT READY · exit proximity 0

Conviction
30/ 100 · maturity 29%
VScore.168
Buildup.2841
EMA entry setup.3522
Fundamentals.2148
Volume profile
POC
176.82
Price vs POC
+17.8%
Overhead supply
7%
Runway
open sky

Value area 170.21201.45 · 7% of 120d volume overhead · clean runway

Contributing sources

No source detections in the last 21 days.

Pattern & cluster
Pattern
NEUTRALhead_and_shoulders:forming
Cluster
NEUTRAL
Forward returns
HorizonReturnMFEState
20d-0.19%-0.19%1/20d
40d-0.19%-0.19%1/40d